Literature DB >> 34617251

Presence or severity of Hashimoto's thyroiditis does not influence basal calcitonin levels: observations from CROHT biobank.

M Cvek1, A Punda1, M Brekalo1, M Plosnić2, A Barić1, D Kaličanin2, L Brčić2, M Vuletić1, I Gunjača2, V Torlak Lovrić1, V Škrabić3, V Boraska Perica4.   

Abstract

PURPOSE: The influence of Hashimoto's thyroiditis (HT) on calcitonin (Ct) production is unresolved question. The aim of this study was to explore if basal Ct levels are influenced by the presence/severity of HT or correlated with clinical phenotypes of HT patients.
METHODS: We included 467 HT patients and 184 control participants, from Croatian Biobank of HT patients (CROHT), in this retrospective study. Calcitonin levels between HT patients and controls were compared using Mann-Whitney test. Ct levels between two subgroups of HT patients, divided by intake of levothyroxine (LT4) therapy, were additionally tested to take into account the illness severity. Spearman rank correlation test was used to analyze correlations between Ct levels and 14 relevant phenotypes.
RESULTS: We have not detected significant differences in median Ct levels between HT patients and controls (2.2 vs 2.35 pg/mL, respectively, P = 0.717) nor in-between two subgroups of HT patients (P = 0.347). We have not detected statistically significant correlations between Ct levels and clinical phenotypes, although we identified three weak nominal correlations: negative correlation of Ct with TgAb in all HT patients (r = - 0.1, P = 0.04); negative correlation of Ct with age in subgroup of HT patients without LT4 therapy (r = - 0.13, P = 0.04); positive correlation of Ct with BSA in subgroup of HT patients on LT4 therapy (r = 0.16, P = 0.042).
CONCLUSION: Our results suggest that HT patients of all disease stages preserve Ct production as healthy individuals and there is no need for Ct measurements in the absence of a nodule. Additional confirmation and clarification of observed nominal correlations are needed due to potential clinical relevance of TgAb and age-dependent Ct decrease in HT women.
© 2021. Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  Age; BSA; Calcitonin; Hashimoto’s thyroiditis; Thyroglobulin antibody (TgAb); Thyroid autoimmunity

Mesh:

Substances:

Year:  2021        PMID: 34617251     DOI: 10.1007/s40618-021-01685-3

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  Calcitonin reserve in different stages of atrophic autoimmune thyroiditis.

Authors:  K Poppe; L A Verbruggen; B Velkeniers; E Finné; J J Body; L Vanhaelst
Journal:  Thyroid       Date:  1999-12       Impact factor: 6.568

2.  Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis.

Authors:  Giorgio Grani; Angela Nesca; Marianna Del Sordo; Anna Calvanese; Giovanni Carbotta; Marta Bianchini; Angela Fumarola
Journal:  Endocr Relat Cancer       Date:  2012-05-24       Impact factor: 5.678

3.  Reference range of serum calcitonin in pediatric population.

Authors:  Maria G Castagna; Laura Fugazzola; Fabio Maino; Danila Covelli; Silvia Memmo; Fausta Sestini; Carla Fioravanti; Chiara Ferraris Fusarini; Carlo Scapellato; Francesco Macchini; Gabriele Cevenini; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2015-03-12       Impact factor: 5.958

Review 4.  Calcitonin therapy in osteoporosis.

Authors:  Manuel Muñoz-Torres; Guillermo Alonso; Mezquita Pedro Raya
Journal:  Treat Endocrinol       Date:  2004

5.  Reference intervals for serum calcitonin in men, women, and children.

Authors:  Jean-Pierre Basuyau; Eric Mallet; Marcelle Leroy; Philippe Brunelle
Journal:  Clin Chem       Date:  2004-10       Impact factor: 8.327

6.  Calcitonin concentrations in lung cancer and non-malignant pulmonary diseases.

Authors:  E Yiakoumakis; C Proukakis; K Raptis; A Korres; N Dondas; V Samaras
Journal:  Oncology       Date:  1987       Impact factor: 2.935

Review 7.  Renal control of calcium, phosphate, and magnesium homeostasis.

Authors:  Judith Blaine; Michel Chonchol; Moshe Levi
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-06       Impact factor: 8.237

8.  Calcitonin levels in normal individuals with new highly sensitive chemiluminescent enzyme immunoassay.

Authors:  H Suzuki
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

9.  Calcitonin, the forgotten hormone: does it deserve to be forgotten?

Authors:  Arnold J Felsenfeld; Barton S Levine
Journal:  Clin Kidney J       Date:  2015-03-20

10.  Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports.

Authors:  Elisa Giannetta; Daniele Gianfrilli; Carlotta Pozza; Rosa Lauretta; Chiara Graziadio; Emilia Sbardella; Alberto Baroli; Roberto Caronna; Piero Chirletti; Andrea Lenzi; Andrea M Isidori
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more
  2 in total

Review 1.  Calcitonin: current concepts and differential diagnosis.

Authors:  Andreas Kiriakopoulos; Periklis Giannakis; Evangelos Menenakos
Journal:  Ther Adv Endocrinol Metab       Date:  2022-05-21       Impact factor: 4.435

Review 2.  Environmental Factors That Affect Parathyroid Hormone and Calcitonin Levels.

Authors:  Mirjana Babić Leko; Nikolina Pleić; Ivana Gunjača; Tatijana Zemunik
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.